Healio Pulmonology highlighted a new Temple-led study on pulmonary arterial hypertension in pregnancy, which showed that maternal-fetal mortality can be reduced to zero through a patient-tailored management effort focused on optimizing right heart function prior to delivery. The retrospective, observational study, which was published in the Journal of Cardiovascular Development and Disease, included seven pregnancies in six women with pulmonary hypertension. All of the pregnancies had excellent outcomes, with 100 percent survival for mothers and infants. The Healio Pulmonology article included comments from Anjali Vaidya, MD, FACC, FASE, FACP, Professor of Medicine at the Lewis Katz School of Medicine at Temple University; Co-Director of the Temple Heart & Vascular Institute’s Pulmonary Hypertension, Right Heart Failure & CTEPH/PTE Program; and lead author on the study.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH